Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms
Journal of Intensive Care Medicine · 2025
DOI: 10.1177/08850666231222470 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Intensive Care Medicine, 2025. Verfasst von Monika Sadlonova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents, Delirium, Long QT Syndrome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 147 Literaturangaben. Gefördert von: National Heart, Lung, and Blood Institute.
Themen: Delir
Abstract (Originalsprache)
Background
Patients experiencing significant agitation or perceptual disturbances related to delirium in an intensive care setting may benefit from short-term treatment with an antipsychotic medication. Some antipsychotic medications may prolong the QTc interval, which increases the risk of potentially fatal ventricular arrhythmias. In this targeted review, we describe the evidence regarding the relationships between antipsychotic medications and QTc prolongation and practical methods for monitoring the QTc interval and mitigating arrhythmia risk.
Methods
Searches of PubMed and Cochrane Library were performed to identify studies, published before February 2023, investigating the relationships between antipsychotic medications and QTc prolongation or arrhythmias.
Results
Most antipsychotic medications commonly used for the management of delirium symptoms (eg, intravenous haloperidol, olanzapine, quetiapine) cause a moderate degree of QTc prolongation. Among other antipsychotics, those most likely to cause QTc prolongation are iloperidone and ziprasidone, while aripiprazole and lurasidone appear to have minimal risk for QTc prolongation. Genetic vulnerabilities, female sex, older age, pre-existing cardiovascular disease, electrolyte abnormalities, and non-psychiatric medications also increase the risk of QTc prolongation. For individuals at risk of QTc prolongation, it is essential to measure the QTc interval accurately and consistently and consider medication adjustments if needed.
Conclusions
Antipsychotic medications are one of many risk factors for QTc prolongation. When managing agitation related to delirium, it is imperative to assess an individual patient's risk for QTc prolongation and to choose a medication and monitoring strategy commensurate to the risks. In intensive care settings, we recommend regular ECG monitoring, using a linear regression formula to correct for heart rate. If substantial QTc prolongation (eg, QTc > 500 msec) is present, a change in pharmacologic treatment can be considered, though a particular medication may still be warranted if the risks of discontinuation (eg, extreme agitation, removal of invasive monitoring devices) outweigh the risks of arrhythmias.
Aims
This review aims to summarize the current literature on relationships between antipsychotic medications and QTc prolongation and to make practical clinical recommendations towards the approach of antipsychotic medication use for the management of delirium-related agitation and perceptual disturbances in intensive care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
- Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Göttingen, Germany.
- Department of Cardiovascular and Thoracic Surgery, University of Göttingen Medical Center, Göttingen, Germany.
- DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.
- Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.
ORCID-Profile: Christopher M Celano
Förderung
- National Heart, Lung, and Blood Institute
Zitieren
APA
Sadlonova, M., Beach, S. R., Funk, M. C., Rosen, J. H., Ramirez Gamero, A. F., Karlson, R. A., Huffman, J. C., & Celano, C. M. (2025). Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666231222470
Vancouver
Sadlonova M, Beach SR, Funk MC, Rosen JH, Ramirez Gamero AF, Karlson RA, et al. Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms. Journal of Intensive Care Medicine. 2025. doi:10.1177/08850666231222470
BibTeX
@article{Sadlonova2025,
author = {Sadlonova, Monika and Beach, Scott R and Funk, Margo C and Rosen, Jordan H and Ramirez Gamero, Andres F and Karlson, Rebecca A and Huffman, Jeff C and Celano, Christopher M},
title = {Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms},
journal = {Journal of Intensive Care Medicine},
year = {2025},
doi = {10.1177/08850666231222470}
}
EUVIMED